Blastic natural killer cell lymphoma/leukemia: A report of seven cases

American Journal of Clinical Pathology

Volumn 117, Issue 1, 2002, Pages 41-50

  Bayerl, Michael G ^a   Rakozy, Christiane K ^a   Mohamed, Anwar N ^a   Vo, Trieu D ^a   Long, Michael ^a   Eilender, David ^a   Palutke, Margarita ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

CD33; CD4; CD56; Cytogenetics; Immunophenotype; Leukemia; Lymphoma; Natural killer cells; Skin

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN;

ADULT; AGED; ARTICLE; BLAST CELL; CELL CLONE; CELL STRUCTURE; CLINICAL ARTICLE; GENE EXPRESSION; GERM LINE; HUMAN; LEUKEMIA; LYMPH NODE; LYMPHOMA; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SKIN; TUMOR RECURRENCE;

ADULT; AGED; ANTIGENS, CD; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, LYMPHOCYTIC; LEUKEMIC INFILTRATION; LYMPH NODES; LYMPHOMA, LYMPHOBLASTIC; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; SKIN;

EID: 0036142942     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/UUXV-YRL8-GXP7-HR4H     Document Type: Article

References (44)

1. Diversification of haematopoietic stem cells to specific lineages
2. Early stages of the development of human T, natural killer and thymic dendritic cells
3. Natural killer cell neoplasms
4. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas
5. Aggressive natural killer cell leukaemia/lymphoma: Report of four cases and review of the literature: Possible existence of a new clinical entity originating from the third lineage of lymphoid cells
6. Blastic natural killer cell leukemia/lymphoma: A clinicopathologic study
7. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
8. Acute agranular CD4positive natural killer cell leukemia
9. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: A case report
10. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity
11. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma
12. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient
13. Blastoid NK cell leukemia/lymphoma with cutaneous involvement
14. Clinicopathologic study of nasal T/NK lymphoma among Japanese
15. CD3- CD56+ nonHodgkin's lymphoma with an aggressive behavior related to multidrug resistance
16. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract
17. CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin
18. Natural killer-cell lymphoma involving the gynecologic tract
19. High-dose chemotherapy with peripheral blood stem cell rescue in blastoid natural killer cell lymphoma
20. Monomorphic agranular natural killer cell lymphoma/leukemia with no EpsteinBarr virus association
21. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse
22. Blastic NK cell lymphoma/leukemia: A clinicopathological study of 23 cases [abstract]
23. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract
24. Blastic NK-cell lymphoma expressing terminal deoxyribonucleotidyl transferase with Homer-Wright type pseudorosettes formation
25. The World Health Organization Classification of Hematological Malignancies: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997
26. Cases of cutaneous and nasal CD56 (NCAM)-positive lymphoma in Japan have differences in immunohistology, genotype and etiology
27. Investigation of karyotypic, morphologic, and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56)
28. Integrins a4b7 and aEb7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis
29. A unique phenotype of skin-associated lymphocytes in humans: Preferential expression of the HECA-452 epitope by benign and malignant cells at cutaneous sites
30. A novel population of CD4+ CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule
31. Selective expansion of cytotoxic T lymphocytes with a CD4+ CD56+ surface phenotype and a T helper 1 profile of cytokine secretion in the liver of chronically infected with hepatitis B virus
32. Homing of CD4+CD56+ T lymphocytes into kidney allografts during tubular necrosis or rejection
33. Proliferation of large granular lymphocytes in patients with systemic lupus erythematosus
34. Acute lymphoblastic leukemia: Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases
35. Reappraisal of the clinical and biologic significance of myeloid antigen expression in childhood acute lymphoblastic leukemia
36. Development of human T and natural killer cells
37. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity
38. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3
39. Malignancies of natural killer (NK) cell precursor: Myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia
40. Single adult human CD34+/Lin-/CD38- progenitors give rise to natural killer cells, B-lineage cells, dendritic cells and myeloid cells
41. Terminal deoxyribonucleotidyl transferase staining on malignant lymphomas in paraffin sections
42. Terminal deoxyribonucleotidyl transferase expression acute myelogenous leukemia and myelodysplasia as determined by flow cytometry
43. Chromosomal translocations are common in natural killer-cell lymphoma/leukemia as shown by spectral karyotyping
44. The t(2;5) in human lymphoma